Fremanezumab effectiveness and tolerability in clinical routine: interim real-world-data of the observational FINESSE study

被引：0
作者：
Straube, A. [1 ]
Broessner, G. [2 ]
Gaul, C. [3 ]
Hamann, X. [4 ]
Kraya, T. [5 ,6 ]
Neeb, L. [7 ,8 ]
机构：
[1] Univ Hosp LMU Munich, Dept Neurol, Munich, Germany
[2] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[3] Headache Ctr Frankfurt, Frankfurt, Germany
[4] Teva GmbH, Ulm, Germany
[5] Hosp Sankt Georg Leipzig gGmbH, Dept Neurol, Headache Ctr Halle, Leipzig, Germany
[6] Univ Hosp Halle, Dept Neurol, Headache Ctr Halle, Halle, Saale, Germany
[7] Helios Global Hlth, Berlin, Germany
[8] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P040
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Fremanezumab Effectiveness and Tolerability in Clinical Routine: Interim Real-World-Data of the Observational FINESSE Study
    Straube, Andreas
    Broessner, Gregor
    Gaul, Charly
    Hamann, Xenia
    Kraya, Torsten
    Neeb, Lars
    CEPHALALGIA, 2023, 43 (1supp) : 243 - 244
  • [2] OBSERVATIONAL MULTICENTER STUDY ON EFFECTIVENESS AND TOLERABILITY OF ALIROCUMAB IN REAL WORLD, THE OMERO STUDY: INTERIM DATA FROM THE FIST 352 PARTICIPANTS
    Pisciotta, L.
    Catapano, A. L.
    Maggioni, A. P.
    Rossi, F.
    Tirone, G.
    Notarianni, L.
    Agnelli, G.
    ATHEROSCLEROSIS, 2021, 331 : E166 - E166
  • [3] Observational multicentre study on effectiveness and tolerability of Alirocumab in real world, the OMERO study: interim data from the first 699 patients
    Catapano, Alberico Luigi
    Maggioni, Aldo Pietro
    Rossi, Francesco
    Tirone, Giampaolo
    Notarianni, Lucia
    Agnelli, Giancarlo
    Cesaro, Arturo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G193 - +
  • [4] Observational multicentre study on effectiveness and tolerability of Alirocumab in real world, the OMERO study: interim data from the first 699 patients
    Catapano, Alberico Luigi
    Maggioni, Aldo Pietro
    Rossi, Francesco
    Tirone, Giampaolo
    Notarianni, Lucia
    Agnelli, Giancarlo
    Cesaro, Arturo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [5] Response to fremanezumab for preventive treatment in migraine in routine clinical practice: First data from the FINESSE study
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Schaurete, I
    Carr, K.
    Neeb, L.
    HEADACHE, 2022, 62 : 160 - 161
  • [6] Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study
    Ashina, M.
    Mitsikostas, D.
    Amin, F. M.
    Kokturk, P.
    Sahin, G.
    Schankin, C.
    Dorman, P.
    Pozo-Rosich, P.
    Lyras, L.
    Myers, C.
    Ahn, A.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1)
  • [7] Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal Mohammad
    Kokturk, Pinar
    Schankin, Christoph J.
    Sahin, Gurdal
    Pozo-Rosich, Patricia
    Dorman, Paul J.
    Nezadal, Tomas
    Poole, Anne Christine
    Martins, Isabel Pavao
    Sumelahti, Marja-Liisa
    Campos, Verena Ramirez
    Ahn, Andrew H.
    Lyras, Leonidas
    Tassorelli, Cristina
    CEPHALALGIA, 2023, 43 (11)
  • [8] Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal M.
    Kokturk, Pinar
    Sahin, Gurdal
    Schankin, Christoph J.
    Dorman, Paul J.
    Pozo-Rosich, Patricia
    Lyras, Leonidas
    Myers, Coleen
    Ahn, Andrew
    Tassorelli, Cristina
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 93 - 94
  • [9] Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study
    Ashina, Messoud
    Mitsikostas, Dimos D.
    Amin, Faisal M.
    Kokturk, Pinar
    Sahin, Gurdal
    Schankin, Christoph J.
    Dorman, Paul J.
    Pozo-Rosich, Patricia
    Lyras, Leonidas
    Myers, Coleen
    Ahn, Andrew H.
    Tassorelli, Cristina
    NEUROLOGY, 2023, 100 (17)
  • [10] Comparing the effectiveness and tolerability of Perampanel and Brivaracetam: a preliminary retrospective, observational study based on real-world data
    Liguori, C.
    Manfredi, N.
    Renna, R.
    Izzi, F.
    Pagliuca, M.
    Pagliuca, F.
    Mercuri, N. B.
    Placidi, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 290 - 290
12345